Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Supreme Cannabis Company Inc. (The) T.FIRE

Consumer Cyclical Healthcare Advertising Agencies Drug Manufacturers - Major
The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.

TSX:FIRE - Post Discussion

Supreme Cannabis Company Inc. (The) > Analyst dropping target price from $0.30 to $0.15 per share
View:
Post by RealistGhost21 on Sep 30, 2020 10:51am

Analyst dropping target price from $0.30 to $0.15 per share

Sept 29th 2020:

The Supreme Cannabis Company (The Supreme Cannabis Company Stock Quote, Chart, News TSX:FIRE) reported strong earnings in its latest quarter but the results weren’t enough to move the needle for Stifel GMP analyst Andrew Partheniou who in an update to clients on Monday reiterated his “Hold” rating while dropping his target price from $0.30 to $0.15 per share.

 
Comment by JiffBeasauce on Sep 30, 2020 10:57am
This guy...  Andrew Partheniou Stifel Nicolaus Wall Street Analyst Ranked #6,219 out of 6,941 Analysts on TipRanks (#13,220 out of 14,562 overall experts) Andrew Partheniou's Performance Success Rate 29%  ...more  
Comment by MoneyTalks7 on Sep 30, 2020 11:03am
Let's not criticize, even mediocre analysts need to be working lol lol
Comment by RealistGhost21 on Sep 30, 2020 12:25pm
Comment by JiffBeasauce on Sep 30, 2020 12:32pm
 I think he’s referring to the fact the analysts you quoted has an under 30% success rate and a -13.9 roi. Bottom 5% of analysts for the sector. Less then one star rating.
Supreme Cannabis Company Inc. (The)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities